ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Mankind Pharma Limited Complete list of announcements declared & dividend announcements by Mankind Pharma Limited MANKIND

Mankind Pharma Limited MANKIND listed on NSE and deals in

Announcements and dividends declared by Mankind Pharma Limited MANKIND

Mankind Pharma signs agreement to buy Panacea Biotec Pharma's domestic biz
Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in FY21; Adar Poonawalla holds 8.6% stake in the firm
Announcement as on 01 February 2022

Panacea Biotec sells domestic formulation assets to Mankind Pharma for Rs 1,908 crore
Panacea said it expects to complete the transaction by the end of this year.
Announcement as on 01 February 2022

Mankind Pharma announces foray into critical care
Saviour Mankind, a dedicated division for life-saving injectables has commenced operation today with products ranging from anti-infectives to stroke and trauma management, the company said in a statement.
Announcement as on 20 January 2022

Mankind Pharma to roll out cheapest coronavirus drug
The full treatment of Molulife (brand name) is expected to cost ₹1,400, RC Juneja, chairman of Mankind Pharma, told ET. The brand is expected to hit this week in the market, he said.
Announcement as on 04 January 2022

Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG
2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy's Laboratories, Manki
Announcement as on 08 July 2021

Announcements by Mankind Pharma Limited first page | Next page | Prev page |

MANKIND Mankind Pharma Limited current price & indicator signals

Moving Averages for Mankind Pharma Limited

  • 5Day Average: 2198.32
  • 12Day Average: 2211.73
  • 20Day Average: 2149.41
  • 50Day Average: 2146.51
  • 100Day Average: 2201.3
  • 150Day Average: 2306.51
  • 200Day Average: 2345.28

MANKIND Indicators & signals

Indicator MACD (12,26,9)

2184.28, 2161.33, 20.58
Indicator MACD is in positive zone

Indicator ADX (14)

10.05, 24.33, 29.76
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MANKIND Mankind Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
13 Fri Mar 2026 2138.90 2128.70 to 2205.00 -3.13% 1 times
12 Thu Mar 2026 2207.90 2184.70 to 2243.50 -1.6% 0.38 times
11 Wed Mar 2026 2243.80 2222.30 to 2256.80 0.27% 0.52 times
10 Tue Mar 2026 2237.70 2169.20 to 2249.30 3.44% 1.3 times
09 Mon Mar 2026 2163.30 2108.30 to 2170.80 -1.08% 1.03 times
06 Fri Mar 2026 2187.00 2178.10 to 2231.70 -1.77% 0.44 times
05 Thu Mar 2026 2226.40 2191.60 to 2239.80 0.87% 0.39 times
04 Wed Mar 2026 2207.20 2195.10 to 2235.00 -1.71% 0.85 times
02 Mon Mar 2026 2245.50 2161.00 to 2251.10 -0.09% 0.68 times
27 Fri Feb 2026 2247.60 2235.00 to 2275.00 -1.41% 0.99 times
26 Thu Feb 2026 2279.70 2145.90 to 2284.90 5.75% 3.44 times
25 Wed Feb 2026 2155.70 2052.80 to 2165.00 4.92% 1 times

Videos related to: MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MANKIND announcements Mankind Pharma Limited announcements and dividends declared NSE

 

Back to top